SGLT2 Inhibitors, Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists, and the Risk of Hypokalemia and Hyperkalemia in a National Cohort of Veterans with Type 2 Diabetes

Authors: Akhil Ramanujam Chakravartula, Sydney Elizabeth Hartsell, Amara Sarwal, Guo Wei, Mckenna R. Nevers, Robert E. Boucher, Niharika Katkam, Augustine Takyi, Jincheng Shen, Tom Greene, Srinivasan Beddhu

Published: 2024-10-28

DOI: 10.1681/asn.2024deq9zff3

Keywords: No keywords found.

Abstract:
No abstract found.

Source: